(cis)-3-(4-(6-(1H-Pyrazol-4-yl)pyrazolo[1,5-a]pyrazin-4-yl)-1H-pyrazol-1-yl)-3-(cyanomethyl)cyclobutane-1-carbonitrile

ID: ALA4781984

Max Phase: Preclinical

Molecular Formula: C19H15N9

Molecular Weight: 369.39

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  N#CC[C@]1(n2cc(-c3nc(-c4cn[nH]c4)cn4nccc34)cn2)C[C@@H](C#N)C1

Standard InChI:  InChI=1S/C19H15N9/c20-3-2-19(5-13(6-19)7-21)28-11-15(10-25-28)18-17-1-4-24-27(17)12-16(26-18)14-8-22-23-9-14/h1,4,8-13H,2,5-6H2,(H,22,23)/t13-,19+

Standard InChI Key:  HAOJZJBZTKOEDO-XVDXERDNSA-N

Molfile:  

 
     RDKit          2D

 28 32  0  0  0  0  0  0  0  0999 V2000
    6.1999   -5.2125    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.0249   -5.2125    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.2778   -5.9971    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6124   -6.4860    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9428   -5.9971    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8965   -7.7235    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6124   -7.3110    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8965   -8.5485    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.3241   -7.7235    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.3241   -8.5485    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6124   -8.9610    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1119   -8.8014    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.6271   -8.1360    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1119   -7.4664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9308   -9.9515    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.3433   -9.2356    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.7943   -8.6234    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0400   -8.9610    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1248   -9.7792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7191   -4.5481    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8491   -3.7335    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0345   -3.6034    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9044   -4.4181    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5488   -2.9371    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0647   -2.2691    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.2999   -5.2583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4750   -5.2503    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6500   -5.2458    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  1  5  1  0
  6  7  1  0
  6  8  1  0
  7  9  2  0
  9 10  1  0
 10 11  2  0
  8 11  1  0
 12 13  2  0
 13 14  1  0
  8 12  1  0
  6 14  2  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 15 19  2  0
 10 18  1  0
  4  7  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 20  1  0
 20  1  1  1
 24 25  3  0
 22 24  1  1
 20 26  1  0
 26 27  1  0
 27 28  3  0
M  END

Alternative Forms

  1. Parent:

    ALA4781984

    ---

Associated Targets(Human)

TYK2 Tclin Tyrosine-protein kinase TYK2 (5029 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
JAK1 Tclin Tyrosine-protein kinase JAK1 (8569 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
JAK2 Tclin Tyrosine-protein kinase JAK2 (12915 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
JAK3 Tclin Tyrosine-protein kinase JAK3 (8349 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 369.39Molecular Weight (Monoisotopic): 369.1450AlogP: 2.53#Rotatable Bonds: 4
Polar Surface Area: 124.27Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 11.41CX Basic pKa: 2.26CX LogP: 0.97CX LogD: 0.97
Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.59Np Likeness Score: -1.13

References

1. Gerstenberger BS,Ambler C,Arnold EP,Banker ME,Brown MF,Clark JD,Dermenci A,Dowty ME,Fensome A,Fish S,Hayward MM,Hegen M,Hollingshead BD,Knafels JD,Lin DW,Lin TH,Owen DR,Saiah E,Sharma R,Vajdos FF,Xing L,Yang X,Yang X,Wright SW.  (2020)  Discovery of Tyrosine Kinase 2 (TYK2) Inhibitor (PF-06826647) for the Treatment of Autoimmune Diseases.,  63  (22): [PMID:32787094] [10.1021/acs.jmedchem.0c00948]

Source